Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Medicinova Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 32 | 35 | +3 |
| Shares | 7.13M | 6.96M | −168.4K (−2.4%) |
| Value | $19.0M | $17.6M | −$1.43M (−7.5%) |
New holders (3)
Institutions that held Medicinova Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 29,133 | $74.0K | 0.00% |
| Qube Research & Technologies Ltd | 25,306 | $64.0K | 0.00% |
| Credit Suisse AG | 1,000 | $3.00K | 0.00% |
Sold out (0)
Institutions that held Medicinova Inc at the end of Q1 2022 and filed for Q2 2022 without it.
None.